Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1988 2
1989 5
1990 4
1991 1
1992 4
1993 2
1994 4
1995 3
1996 1
1997 1
1999 3
2000 2
2001 4
2002 1
2003 1
2004 3
2005 1
2006 4
2007 1
2008 2
2009 3
2010 1
2011 6
2012 4
2013 4
2015 1
2016 1
2017 1
2018 2
2019 3
2020 2
2021 5
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

81 results
Results by year
Filters applied: . Clear all
Page 1
Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade.
Patel RB, Hernandez R, Carlson P, Grudzinski J, Bates AM, Jagodinsky JC, Erbe A, Marsh IR, Arthur I, Aluicio-Sarduy E, Sriramaneni RN, Jin WJ, Massey C, Rakhmilevich AL, Vail D, Engle JW, Le T, Kim K, Bednarz B, Sondel PM, Weichert J, Morris ZS. Patel RB, et al. Among authors: rakhmilevich al. Sci Transl Med. 2021 Jul 14;13(602):eabb3631. doi: 10.1126/scitranslmed.abb3631. Sci Transl Med. 2021. PMID: 34261797 Free PMC article.
Interleukin-12 as an in situ cancer vaccine component: a review.
Cheng EM, Tsarovsky NW, Sondel PM, Rakhmilevich AL. Cheng EM, et al. Among authors: rakhmilevich al. Cancer Immunol Immunother. 2022 Jan 13. doi: 10.1007/s00262-022-03144-1. Online ahead of print. Cancer Immunol Immunother. 2022. PMID: 35024897 Review.
T-cell-independent antitumor effects of CD40 ligation.
Rakhmilevich AL, Alderson KL, Sondel PM. Rakhmilevich AL, et al. Int Rev Immunol. 2012 Aug;31(4):267-78. doi: 10.3109/08830185.2012.698337. Int Rev Immunol. 2012. PMID: 22804571 Free PMC article. Review.
Short-course neoadjuvant in situ vaccination for murine melanoma.
Aiken TJ, Komjathy D, Rodriguez M, Stuckwisch A, Feils A, Subbotin V, Birstler J, Gillies SD, Rakhmilevich AL, Erbe AK, Sondel PM. Aiken TJ, et al. Among authors: rakhmilevich al. J Immunother Cancer. 2022 Jan;10(1):e003586. doi: 10.1136/jitc-2021-003586. J Immunother Cancer. 2022. PMID: 35039460 Free article.
MUC16 suppresses human and murine innate immune responses.
Felder M, Kapur A, Rakhmilevich AL, Qu X, Sondel PM, Gillies SD, Connor J, Patankar MS. Felder M, et al. Among authors: rakhmilevich al. Gynecol Oncol. 2019 Mar;152(3):618-628. doi: 10.1016/j.ygyno.2018.12.023. Epub 2019 Jan 6. Gynecol Oncol. 2019. PMID: 30626487 Free PMC article.
In situ Vaccine Plus Checkpoint Blockade Induces Memory Humoral Response.
Baniel CC, Heinze CM, Hoefges A, Sumiec EG, Hank JA, Carlson PM, Jin WJ, Patel RB, Sriramaneni RN, Gillies SD, Erbe AK, Schwarz CN, Pieper AA, Rakhmilevich AL, Sondel PM, Morris ZS. Baniel CC, et al. Among authors: rakhmilevich al. Front Immunol. 2020 Jul 24;11:1610. doi: 10.3389/fimmu.2020.01610. eCollection 2020. Front Immunol. 2020. PMID: 32849544 Free PMC article.
Combination of radiation therapy, bempegaldesleukin, and checkpoint blockade eradicates advanced solid tumors and metastases in mice.
Pieper AA, Rakhmilevich AL, Spiegelman DV, Patel RB, Birstler J, Jin WJ, Carlson PM, Charych DH, Hank JA, Erbe AK, Overwijk WW, Morris ZS, Sondel PM. Pieper AA, et al. Among authors: rakhmilevich al. J Immunother Cancer. 2021 Jun;9(6):e002715. doi: 10.1136/jitc-2021-002715. J Immunother Cancer. 2021. PMID: 34172518 Free PMC article.
Radiation Augments the Local Anti-Tumor Effect of In Situ Vaccine With CpG-Oligodeoxynucleotides and Anti-OX40 in Immunologically Cold Tumor Models.
Pieper AA, Zangl LM, Speigelman DV, Feils AS, Hoefges A, Jagodinsky JC, Felder MA, Tsarovsky NW, Arthur IS, Brown RJ, Birstler J, Le T, Carlson PM, Bates AM, Hank JA, Rakhmilevich AL, Erbe AK, Sondel PM, Patel RB, Morris ZS. Pieper AA, et al. Among authors: rakhmilevich al. Front Immunol. 2021 Nov 15;12:763888. doi: 10.3389/fimmu.2021.763888. eCollection 2021. Front Immunol. 2021. PMID: 34868010 Free PMC article.
Combining Immunocytokine and Ex Vivo Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2+ Murine Neuroblastoma.
Bates PD, Rakhmilevich AL, Cho MM, Bouchlaka MN, Rao SL, Hales JM, Orentas RJ, Fry TJ, Gilles SD, Sondel PM, Capitini CM. Bates PD, et al. Among authors: rakhmilevich al. Front Immunol. 2021 Aug 19;12:668307. doi: 10.3389/fimmu.2021.668307. eCollection 2021. Front Immunol. 2021. PMID: 34489927 Free PMC article.
81 results